ENLV - Enlivex Therapeutics Ltd
IEX Last Trade
1.29
0.045 3.488%
Share volume: 25,699
Last Updated: Fri 30 Aug 2024 09:57:14 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.24
0.05
3.61%
Summary score
21%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.33%
Return on assets
-17.54%
Return on sales
0%
Return on invested capital
121.52%
Total debt ratio
19.16%
Debt ratio change over timeo
-0.79%
Current Ratio
5.87%
Quick Ratio
0%
Cash Position Ratio
3.94%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.76%
Return on assets
-6.09%
Return on sales
0%
Return on invested capital
79.67%
Total debt ratio
14.7%
Debt ratio change over timeo
-0.8%
Current Ratio
7.04%
Quick Ratio
0%
Cash Position Ratio
2%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.46%
Return on assets
-5.87%
Return on sales
0%
Return on invested capital
81.48%
Total debt ratio
14.6%
Debt ratio change over time
-0.81%
Current Ratio
7.23%
Quick Ratio
0%
Cash Position Ratio
1.44%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-118.17%
Return on assets
-113.36%
Return on sales
0%
Return on invested capital
-3.46%
Total debt ratio
-78.59%
Debt ratio change over time
-0.79%
Current Ratio
4.46%
Quick Ratio
0%
Cash Position Ratio
2.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ENLV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -22.33% | -3.65% | 12.3% | 6.42% |
| Return on assets | -17.54% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 121.52% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 61% |
| Total debt ratio | 19.16% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.79% | 224.03% | 6.03% | 1.46% |
| Dept financing | 5% | 50% | 19% | 8% |
| Current Ratio | 7.04% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 2% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 21% | 44% | 48% |
| Short-term ratios | ENLV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.76% | -16.17% | 18.05% | 7.63% |
| Return on assets | -6.09% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 79.67% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 36% | 70% | 66% |
| Total debt ratio | 14.7% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.8% | 851.68% | 10.97% | 0.58% |
| Dept financing | 4% | 50% | 21% | 8% |
| Current Ratio | 7.04% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 2% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 42% | 29% | 55% |